Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
- Creator: Mercieca-Bebber, R. , Barnes, E. H. , Leung, J. , Wang, T. , Bohmer, R. , Cameron, D. , Simes, J. , Gebski, V. , Smithers, M. , Thomas, J. , Zalcberg, J. , Barbour, A. P. , Wilson, K. , Samoon, Z. , Walpole, E. , Mai, T. , Ackland, S. , Burge, M. , Dickie, G. , Watson, D.
- Resource Type: journal article
- Date: 2022
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
- Creator: Barbour, A. P. , Walpole, E. T. , Mai, G. T. , Barnes, E. H. , Watson, D. I. , Ackland, S. P. , Martin, J. M. , Burge, M. , Finch, R. , Karapetis, C. S. , Shannon, J. , Nott, L. M. , Varma, S. , Marx, G. , Falk, G. L. , Gebski, V. , Oostendorp, M. , Wilson, K. , Thomas, J. , Lampe, G.
- Resource Type: journal article
- Date: 2020
Dose intensity in anthracycline-based chemotherapy for metastatic breast cancer: mature results of the randomised clinical trial ANZ 9311
- Creator: Ackland, Stephen P. , Gebski, V. , Forbes, J. F. , Coates, A. S. , Zdenkowski, N. , Wilson, A. , Green, M. , Tees, S. , Dhillon, H. , Van Hazel, G. , Levi, J. , Simes, R. J.
- Resource Type: journal article
- Date: 2019
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptorpositive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial
- Creator: Zdenkowski, N. , Forbes, J. F. , Mann, G. B. , Coates, A. S. , Gebski, V. , Davies, L. , Thornton, R. , Reaby, L. , Cuzick, J. , Green, M. , Boyle, F. M. , Kannourakis, G. , Gill, P. G. , Bayliss, E. , Saunders, C. , Della-Fiorentina, S. , Kling, N. , Campbell, I.
- Resource Type: journal article
- Date: 2016
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
- Creator: McCarthy, N. , Boyle, F. , Gebski, V. , Veillard, A. S. , Zannino, D. , Wilcken, N. , Reaby, L. , Lindsay, D. F. , Badger, H. D. , Forbes, J. F. , Zdenkowski, N. , Bull, J. , Leong, E. , Simpson, A. , Kannourakis, G. , Francis, P. A. , Chirgwin, J. , Abdi, E.
- Resource Type: journal article
- Date: 2014
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
- Creator: Wagner, U. , Marth, C. , Gebski, V. , Lauraine, E. P. , Largillier, R. , Kaern, J. , Brown, C. , Heywood, M. , Bonaventura, T. , Vergote, I. , Piccirillo, M. C. , Fossati, R.
- Resource Type: journal article
- Date: 2012
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer
- Creator: Green, M. D. , Francis, P. A. , Gebski, V. , Harvey, V. , Karapetis, C. , Chan, A. , Snyder, R. , Fong, A. , Basser, R. , Forbes, J. F. , Australian New Zealand Breast Cancer Trials Group
- Resource Type: journal article
- Date: 2009